Insmed Announces FDA Acceptance for Filing of New Drug Application for ALIS in NTM Lung Disease Caused by MAC
Go back to Insmed Announces FDA Acceptance for Filing of New Drug Application for ALIS in NTM Lung Disease Caused by MAC| INSMED (NASDAQ: INSM) | Delayed: 98.61 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $98.61 | 52 Week High | $19.30 | |||
| Open | $98.61 | 52 Week Low | $9.02 | |||
| Day High | $98.61 | P/E | N/A | |||
| Day Low | $98.61 | EPS | $-1.69 | |||
| Volume | 25 | |||||
